Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine. - Study Results -...
Vascular graft occlusion * # participants affected / at risk 1/887 (0.11%) 0/445 (0.00%) ...https://clinicaltrials.gov/ct2/show/results/NCT00835237?sect=X34015&view=results
SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries - Study...
Vascular graft occlusion * 1 28/897 (3.12%) 29. 1/903 (0.11%) 1. ... Total Occlusion (per patient)  Measure Type: Number. Unit of ... The impact of a second arterial graft on 5-year outcomes after coronary artery bypass grafting in the Synergy Between ... Coronary Artery By-pass Graft (CABG... Percutaneous coronary intervention ... Arm/Group Description: Coronary Artery By-pass ... Coronary Artery By-pass Graft (CABG... Percutaneous coronary intervention ... Arm/Group Description: Coronary Artery By-pass ...https://clinicaltrials.gov/ct2/show/results/NCT00114972?sect=X15
Cardiac saphenous vein bypass graft disease.
However, up to 40% of saphenous vein grafts will occlude within 10 years of surgery. T ... Coronary artery bypass grafting is an effective treatment for myocardial ischaemia and is particularly important in patients ... Graft Occlusion, Vascular / pathology, physiopathology*. Humans. Hyperlipidemias / physiopathology. Nitric Oxide / physiology. ... 0/Vascular Endothelial Growth Factor A; 10102-43-9/Nitric Oxide From MEDLINE®/PubMed®, a database of the U.S. National Library ...http://www.biomedsearch.com/nih/Cardiac-saphenous-vein-bypass-graft/15478036.html
Lipoprotein(a) and other serum lipid subfractions influencing primary patency after infrainguinal percutaneous transluminal...
Graft Occlusion, Vascular / blood, etiology*. Humans. Leg / blood supply*. Lipoproteins / blood*. Male. Middle Aged. Peripheral ... Department of Specialized Vascular Surgery and Anesthesiology, Alma Mater Studiorum, University of Bologna, Policlinico S. ... Next Document: A standardized multi-branched thoracoabdominal stent-graft for endovascular aneurysm repair.. ... Vascular Diseases / blood*, therapy. Retrospective Studies. Risk Factors. Stents. Treatment Outcome. Vascular Patency / ...http://www.biomedsearch.com/nih/Lipoproteina-other-serum-lipid-subfractions/19642794.html
Patente US4578079 - Tetrapeptide - Google Patentes
Method and composition for treating vascular graft occlusion. US5654267 *. 30 Nov 1994. 5 Ago 1997. La Jolla Cancer Research ... An example of such an approach is the induction of endothelial cell growth on a prosthetic blood vessel or vascular graft, ... The polypeptide fragment of claim 1 coupled to and forming part of a vascular graft. ... The polypeptide fragment of claim 12 coupled to and forming part of a vascular graft. ...http://www.google.es/patents/US4578079?hl=es&dq=flatulence
Clinical, angiographic, and intravascular ultrasound characteristics of early saphenous vein graft failure.
BACKGROUND: Saphenous vein grafts remain patent for approximately 10 years; however, up to 15% to 20% of SVGs become occluded ... We sought to examine saphenous vein graft (SVG) lesions that fail within the first year after operation. ... Graft Occlusion, Vascular / diagnosis*, etiology*, physiopathology. Humans. Isoenzymes / blood. Male. Middle Aged. ... Graft ages were 6.0 +/- 2.9 months and 105.4 +/- 50.8 months, respectively. The early SVG failure lesion location was more ...http://www.biomedsearch.com/nih/Clinical-angiographic-intravascular-ultrasound-characteristics/15234406.html
Pletal - Side Effects, Uses, Dosage, Overdose, Pregnancy, Alcohol | RxWiki
Graft Occlusion, Vascular. *Intermittent Claudication. *Peripheral Vascular Diseases. How long have you been taking it?. Choose ...http://www.rxwiki.com/pletal
NEURORADIOLOGY & INTERVENTIONAL RADIOLOGY
Peripheral vascular occlusion. Acute thromboembolism. Vascular graft occlusion. *Aortic stenting for aortic dissections & ... The division provides overall management of all neurovascular & Peripheral vascular disease and also arranges medical & public ... stenting for peripheral vascular disease , Laser ablations of varicose veins & incompetent perforators . These endovascular ...http://klehospital.org/index.php/neuroradiology-interventional-radiology/
One-week postoperative patency of lower extremity in situ bypass graft comparing epidural and general anesthesia - Danish...
Aged; Aged, 80 and over; Amputation; Anesthesia, Epidural; Anesthesia, General; Comorbidity; Female; Graft Occlusion, Vascular ... Graft occlusion within 7 days after surgery was reported in 93 patients, with a similar incidence in the epidural (10.1%) and ... the incidence of graft occlusion was also similar in the 2 groups at 14.0% and 9.4%, respectively (P = 0.262). CONCLUSION: This ... Vascular Patency; Vascular Surgical Procedures; Comparative Study; Journal Article Main Research Area: Medical science ...http://www.forskningsdatabasen.dk/catalog/255028722
Response to Letter to the Editor: 'Re: Endograft Limb Occlusion in EVAR: Iliac Tortuosity Quantified by Three Different Indices...
Aortic Aneurysm, Abdominal; Blood Vessel Prosthesis; Female; Graft Occlusion, Vascular; Humans; Iliac Artery; Male; Vascular ... European Journal of Vascular and Endovascular Surgery, 2014, Vol 48, Issue 6 Keywords: ... Response to Letter to the Editor: 'Re: Endograft Limb Occlusion in EVAR: Iliac Tortuosity Quantified by Three Different Indices ...http://www.forskningsdatabasen.dk/catalog/271161828
SelfDecode | Genome Analysis
Graft Occlusion, Vascular PLAU. Wegener's Granulomatosis PRTN3. Growth Disorders ADAMTSL2. Hand Deformities, Congenital ...https://www.selfdecode.com/molecular-function/GO:0008233/
"The effect of graft configuration on 30-day failure of infrapopliteal " by Bao-Ngoc Nguyen, Richard F. Neville et al.
Graft Occlusion, Vascular--etiology; Peripheral Arterial Disease--surgery; Popliteal Artery--surgery; Prosthesis Design; ... Nguyen, B.N., Neville, R.F., Abugideiri, M., Amdur, R., Sidawy, A.N. (2014). The effect of graft configuration on 30-day ... The effect of graft configuration on 30-day failure of infrapopliteal bypasses ...https://hsrc.himmelfarb.gwu.edu/smhs_surgery_facpubs/143/
U.S. National Institutes of Health | Netdata
Transplantation, Kidney,Graft Occlusion, Vascular. Device: Contrast-enhanced dynamic MRI. https://ClinicalTrials.gov/show/ ...http://www.netdata.com/netsite/08750f34/us-national-institutes-of-health?p=4961
Patent US4678468 - Cardiovascular prosthesis - Google Patents
In the area of small diameter arterial repair, however, vascular grafts have not been accepted because of prompt occlusion ... One of the biggest problems for the practical application of small diameter vascular graft is the occlusion before its ... A vascular graft of over 10 mm diameter has practically little trouble in repairing the damaged artery, however, vascular ... Using the vascular graft of 3 mm diameter obtained in the Example 5, a part of femoral artery of adult dog was replaced. Each ...http://www.google.com/patents/US4678468?dq=%22tom+parker%22
Takayasu's arteritis - The Clinical Advisor
Bypass grafts are superior to stenting of vascular occlusions.) Numano, F. "Differences in clinical presentation and outcome in ... "Takayasu's arteritis: vascular interventions and outcomes". J Rheumatol. vol. 31. 2004 Jan. pp. 102-6. ... Stenting is less favorable due to high rates of re-occlusion. For many patients, surgical management is not necessary due to ... D. Coronary Artery Disease or Peripheral Vascular Disease.. While there is no standard adjustment of corticosteroid dose in the ...https://www.clinicaladvisor.com/hospital-medicine/takayasus-arteritis/article/604654/
The global market for cardiovascular devices should reach $59.1 billion by 2022
... and other vascular surgery devices like endovascular grafts, IVC filters and occlusion devices. The research uncovers many ...https://www.medindia.net/health-press-release/The-global-market-for-cardiovascular-devices-should-reach-591-billion-by-2022-354681-1.htm
US5731326A - PDGF antagonists II - Google Patents
... reduction atherectomy or anastomosis of a vascular graft. The non-peptide PDGF antagonists may optionally be administered ... The methods are useful in reducing intimal hyperplasia due to, for example, vascular injuries resulting from angioplasty, ... This proliferative process is also manifested in the occlusion of vascular grafts (both natural, including autologous and ... Hyperplasia may also occur as a delayed response in response to, e.g., emplacement of a vascular graft or organ transplantation ...https://patents.google.com/patent/US5731326
Embolic Protection With Filtering or Occlusion Balloons During Saphenous Vein Graft Stenting Retrieves Identical Volumes and...
Conclusions- During saphenous vein graft interventions, particulate retrieved with a vascular filtering device or an occlusion ... Vascular filtering devices may offer superiority over occlusion devices in ease of use, patient tolerance, visualization, and ... Novel approaches to embolic protection, specifically vascular filtering rather than occlusion, have been hampered by the notion ... Embolic Protection With Filtering or Occlusion Balloons During Saphenous Vein Graft Stenting Retrieves Identical Volumes and ...http://circ.ahajournals.org/content/109/14/1735
Patent US4892539 - Vascular graft - Google Patents
A vascular tubular graft of a woven fabric with a single velour outside (external) surface and a smooth interior surface, said ... Perfusion-occlusion apparatus. US6171334. 17 Jun 1998. 9 Jan 2001. Advanced Cardiovascular Systems, Inc.. Expandable stent and ... This invention is directed to vascular grafts of synthetic fibers. Vascular grafts (prothesis) are currently used to replace ... self-supporting woven vascular graft. US5282847 *. 15 Jul 1992. 1 Feb 1994. Medtronic, Inc.. Prosthetic vascular grafts with a ...http://www.google.ca/patents/US4892539
Patent US20070299497 - Implantable vascular graft - Google Patents
Disclosed is a tubular endoluminal vascular prosthesis, useful in treating, for example, an abdominal aortic aneurysm. The ... Silicon micro machined occlusion implant. US5860998 *. Nov 25, 1996. Jan 19, 1999. C. R. Bard, Inc.. Deployment device for ... Woven vascular graft. US4907336 *. Sep 9, 1988. Mar 13, 1990. Cook Incorporated. Method of making an endovascular stent and ... Expandable supportive endoluminal grafts. US5733325 *. May 6, 1996. Mar 31, 1998. C. R. Bard, Inc.. Non-migrating vascular ...http://www.google.com/patents/US20070299497?dq=7,134,016
s ꒲ | [ g: S Ǒ u F2022 N ܂ł̐ E s
... and other vascular surgery devices like endovascular grafts, IVC filters and occlusion devices. ... Endovascular Grafts *IVC Filters *Vascular Clamps Chapter 9: Competitive Landscape. *Major Players and Market Share *Mergers ... Figure 24 Global Other Vascular Devices Market, by Type, 2016-2022 ($ Billions) *Figure 25 Global Endovascular Grafts Market, ... Other Vascular Surgery Devices Chapter 5: Market Breakdown by Region. *Global Cardiovascular Devices Market *North America *USA ...https://www.gii.co.jp/report/bc599054-cardiovascular-devices-global-markets.html
Patent US6468301 - Repositionable and recapturable vascular stent/graft - Google Patents
A collapsible medical device and associated method for grafting a lumen of selected organs and vessels, wherein the medical ... Covered self-expanding vascular occlusion device. US5928248. 25 Feb 1998. 27 Jul 1999. Biosense, Inc.. Guided deployment of ... Thinly woven flexible graft. US5713948. 19 Jul 1995. 3 Feb 1998. Uflacker; Renan. Adjustable and retrievable graft and graft ... Adjustable and retrievable graft and graft delivery system for stent-graft system and methods of implantation. ...http://www.google.com.au/patents/US6468301
US7351257B2 - Vascular graft device - Google Patents
A vascular graft device includes a semipermeable inner wall surrounding a passage. A nonpermeable outer wall surrounds the ... A method of limiting occlusion in a vascular graft device comprising: providing the vascular graft device with a semi permeable ... when implanted, the vascular graft device 16 can be bent. The vascular graft device 16 has an inner semipermeable wall 24 which ... The present invention also provides a method of limiting occlusion in a vascular graft device including providing the vascular ...https://patents.google.com/patent/US7351257B2/en
Patent US5354310 - Expandable temporary graft - Google Patents
A flexible graft covers the wire mesh so that as the mesh expands, the graft contacts inner wall linings of a blood vessel, ... The implant is intended to be inserted into the patient and expanded to bring a graft into contact with inner wall linings of a ... Method of forming medical devices: intra-vascular occlusion devices. US6371969. Dec 3, 1999. Apr 16, 2002. Scimed Life Systems ... 4, the flexible graft opens, at least at its distalmost end, and allows blood flow to enter the graft and expand the graft to ...http://www.google.com/patents/US5354310?dq=6289460
List of MeSH codes (C23) - Wikipedia
... graft occlusion, vascular MeSH C23.550.767.600 --- malignant hyperthermia MeSH C23.550.767.700 --- pain, postoperative MeSH ... vascular fistula MeSH C23.300.575.950.150 --- arterio-arterial fistula MeSH C23.300.575.950.250 --- arteriovenous fistula MeSH ...https://en.wikipedia.org/wiki/List_of_MeSH_codes_(C23)